Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Research

. 2021; 12(1): 151-157


PROGNOSTIC VALUE OF INFLAMMATORY MARKERS IN PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROME

Babu Reddy, Praneeth Suryadevara, Natraj setty, Jayashree Kharge, Yeriswamy M.C, Srinivas B.C, Nagesh C.M, Manjuna Manjunath C.N.

Abstract
Objective: The objective of the study is to study the use of IL6, IL10, TNF, CRP, neutrophil-lymphocyte ratio (NLR) as a prognostic biomarker for patients presenting with the acute coronary syndrome.
Background:
ACS is the most common cause of death worldwide, but mortality due to Coronary artery disease slowly came down and reached a plateau. ACS occurs in response to inflammation, plaque rupture and subsequent thrombosis, progressive mechanical obstruction, and dynamic obstruction.
Methods:
It is a Prospective study of 100 patients, both Male & Female with ACS admitted to the SJICR with ACS, were subjected to the Full clinical evaluation including history and physical examination with particular emphasis on risk factors.
Results:
Most of the patients studied were STEMI; only seven patients of NSTEMI were included. The male to female ratio was 3.55. The most commonly associated risk factors were smoking, Diabetes mellitus, hypertension. STEMI patients had a shorter window period compared to NSTEMI. The mean duration of hospitalization was three days. Inflammatory markers were compared across various TIMI risk scores. When compared to the TIMI score of 4, HsCRP shows a significant correlation. While other inflammatory markers showed higher values with higher TIMI scores but P value was not significant.
Conclusion:
NLR, HsCRP, IL6, IL10 are significantly associated with TIMI, GRACE, KILLIP risk scoring systems. Inflammatory markers except TNF, shows the correlation with mortality, morbidity, the extent of CAD. These markers explain other domain of pathogenesis in ACS which is a potential target for newer therapeutics.

Key words: Inflammatory markers, Acute Coronary Syndrome, STEMI



Similar Articles

Safe Zones for Percutaneous Carpal Tunnel Release.
Wu PT, Chern TC, Wu TT, Shao CJ, Wu KC, Kuo LC, Jou IM
Hand clinics. 2022; 38(1): 83-90

Contributing factors common to COVID‑19 and gastrointestinal cancer.
Kostoff RN, Briggs MB, Kanduc D, Shores DR, Kovatsi L, Drakoulis N, Porter AL, Tsatsakis A, Spandidos DA
Oncology reports. 2022; 47(1):

Cost-Effectiveness of Sonography-Guided Surgery.
Kinanga R, Moungondo F
Hand clinics. 2022; 38(1): 65-73

Preoperative Evaluation of Thenar Muscles in Carpal Tunnel Syndrome by Ultrasonography.
Nagura I, Kanatani T, Harada Y, Takase F, Inui A, Mifune Y, Kuroda R
Hand clinics. 2022; 38(1): 55-58

Sonographic Diagnosis of Carpal Tunnel Syndrome.
Kluge S, Langer M, Schelle T
Hand clinics. 2022; 38(1): 35-53


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.



ScopeMed Web Sites